From January 1, 2024 to March 31, 2024, the company has repurchased 312,170 shares, representing 0.29% for $298.09 million. With this, the company has completed the repurchase of 2,253,328 shares, representing 2.11% for $1,769.01 million under the buyback announced on February 3, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
980.2 USD | +1.06% | -0.49% | +11.60% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
+11.91% | 118B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on February 3, 2023.